Paid Clinical Trials Paid Clinical Trials > Browse Categories > Substance Abuse > Drug Addiction > Hallucinogen Addiction

Hallucinogen Addiction

Hallucinogen Addiction

All Categories Substance Abuse » Drug Addiction » Hallucinogen Addiction


  • Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia

    Conditions:   Cannabis Dependence;   Marijuana Dependence
    Interventions:   Drug: Dronabinol;   Drug: Clonidine;   Drug: Placebo
    Sponsors:   Mclean Hospital;   Mclean Hospital;   Brain and Behavior Research Foundation (formerly NARSAD)
    Recruiting - verified May 2012
  • The Effects of Cannabinoid on Patients With Non-GERD Related Non Cardiac Chest Pain

    Condition:   Chest Pain
    Interventions:   Drug: Marinol;   Drug: Placebo
    Sponsors:   University of Iowa;   University of Iowa
    Recruiting - verified May 2012
  • Cannabis Effects on Driving-related Skills of Young Drivers

    Condition:   Psychomotor Impairment
    Interventions:   Drug: delta-9-tetrahydrocannabinol;   Drug: Placebo
    Sponsors:   Centre for Addiction and Mental Health;   Centre for Addiction and Mental Health;   Canadian Institutes of Health Research (CIHR);   Health Canada
    Not yet recruiting - verified May 2012
  • The Effects of ∆-9-THC and Naloxone in Humans

    Condition:   Healthy
    Interventions:   Drug: Naloxone;   Drug: Delta-9-THC;   Drug: Placebo
    Sponsors:   Yale University;   Yale University
    Recruiting - verified May 2012
  • The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain

    Conditions:   Postsurgical Pain;   Abdominal Pain;   Chronic Pain
    Interventions:   Drug: Tetrahydrocannabinol;   Drug: Placebo
    Sponsors:   Radboud University;   Radboud University;   European Union
    Not yet recruiting - verified February 2012
  • Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence

    Condition:   Alcohol Dependence
    Intervention:   Drug: Psilocybin
    Sponsors:   University of New Mexico;   University of New Mexico;   Heffter Research Institute
    Recruiting - verified February 2012
  • Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain

    Conditions:   Pancreatitis, Chronic;   Abdominal Pain;   Chronic Pain
    Interventions:   Drug: Tetrahydrocannabinol;   Drug: Placebo
    Sponsors:   Radboud University;   Radboud University;   European Union
    Not yet recruiting - verified February 2012
  • A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours

    Condition:   Solid Tumour
    Intervention:   Drug: Dexanabinol
    Sponsors:   e-Therapeutics PLC;   e-Therapeutics PLC
    Not yet recruiting - verified January 2012
  • Effects of Dronabinol (Oral THC) on Cannabis Use

    Condition:   Marijuana Smoking
    Interventions:   Drug: Dronabinol;   Drug: Placebo
    Sponsors:   Johns Hopkins University;   Johns Hopkins University;   National Institute on Drug Abuse (NIDA)
    Recruiting - verified November 2010
  • Delta-THC in Behavioral Disturbances in Dementia

    Conditions:   Dementia;   Behavioral and Psychological Symptoms of Dementia
    Interventions:   Drug: Delta(9)-tetrahydrocannabinol (Delta-THC);   Drug: Delta(9)-tetrahydrocannabinol;   Drug: Placebo;   Drug: Delta(9)-tetrahydrocannabinol (Delta-THC)
    Sponsors:   Radboud University;   Radboud University
    Recruiting - verified March 2012
  • Effect of Cannabinoids on Spasticity and Neuropathic Pain in Spinal Cord Injured Persons

    Condition:   Muscle Spasticity as a Result of Spinal Cord Injury
    Interventions:   Drug: nabilone 0.5 mg;   Drug: placebo
    Sponsors:   University of Manitoba;   University of Manitoba;   The Manitoba Spinal Cord Injury Research Fund;   Canadian Paraplegic Association
    Not yet recruiting - verified April 2011
  • Study Comparing Three Doses of MDMA Along With Psychotherapy in Veterans With Posttraumatic Stress Disorder

    Condition:   Posttraumatic Stress Disorder
    Interventions:   Drug: 3,4-methylenedioxymethamphetamine;   Drug: 3,4-methylenedioxymethamphetamine;   Drug: 3,4-methylenedioxymethamphetamine
    Sponsors:   Multidisciplinary Association for Psychedelic Studies;   Multidisciplinary Association for Psychedelic Studies
    Recruiting - verified April 2012
  • Neurobiology and Pharmacokinets of Acute MDMA Administration

    Condition:   Substance-Related Disorders
    Interventions:   Drug: MDMA;   Drug: (+/-)3,4-methylenedioxymethamphetamine Hydrochloride, MDMA HCI Capsules
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute on Drug Abuse (NIDA)
    Recruiting - verified May 2011
  • Dronabinol Naltrexone Treatment for Opioid Dependence

    Condition:   Opioid Dependence
    Interventions:   Drug: injectable naltrexone plus dronabinol;   Drug: Naltrexone plus placebo
    Sponsors:   New York State Psychiatric Institute;   New York State Psychiatric Institute;   National Institute on Drug Abuse (NIDA)
    Recruiting - verified May 2012
  • Combined Pharmacotherapy for Cannabis Dependency

    Conditions:   Cannabis Dependence;   Marijuana Dependence
    Interventions:   Drug: Lofexidine and Dronabinol;   Drug: Placebo
    Sponsors:   New York State Psychiatric Institute;   New York State Psychiatric Institute;   National Institute on Drug Abuse (NIDA)
    Recruiting - verified April 2012
  • Human Psychopharmacology of Salvinorin A

    Condition:   Healthy
    Intervention:   Drug: Salvinorin A
    Sponsors:   Johns Hopkins University;   Johns Hopkins University;   National Institute on Drug Abuse (NIDA)
    Recruiting - verified June 2011
  • Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)

    Condition:   Posttraumatic Stress Disorders
    Interventions:   Drug: Tetrahydrocannabinol;   Other: Placebo
    Sponsors:   Hadassah Medical Organization;   Hadassah Medical Organization
    Recruiting - verified July 2011
  • Effects of Delta-9-THC and Iomazenil in Healthy Humans

    Conditions:   Schizophrenia;   Mental Disorders;   Psychotic Disorders
    Interventions:   Drug: THC and Iomazenil;   Drug: Placebo (control)
    Sponsors:   Yale University;   Yale University
    Recruiting - verified July 2011
  • Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

    Conditions:   Schizophrenia;   Dual Diagnosis;   Schizoaffective Disorder;   Psychotic Disorder;   Cannabis Use Disorder
    Interventions:   Drug: Dronabinol;   Drug: Cannabis
    Sponsors:   Dartmouth-Hitchcock Medical Center;   Dartmouth-Hitchcock Medical Center;   National Institute on Drug Abuse (NIDA);   Indiana University;   Columbia University;   University of Vermont;   University of Massachusetts, Worcester
    Recruiting - verified January 2012
  • The Effect of Prescription Medications in Marijuana Users

    Condition:   Marijuana Abuse
    Intervention:   Drug: bupropion, diazepam, dronabinol, ramelteon (Investigational Drug)
    Sponsors:   Johns Hopkins University;   Johns Hopkins University;   National Institute on Drug Abuse (NIDA)
    Recruiting - verified May 2009
  • Psilocybin and Spiritual Practice

    Condition:   Healthy
    Interventions:   Drug: psilocybin;   Behavioral: Intensity of support for spiritual practice;   Behavioral: Number of sessions
    Sponsors:   Johns Hopkins University;   Johns Hopkins University;   Fetzer Institute;   The CSP Fund of the San Francisco Foundation
    Recruiting - verified June 2011
  • Cannabinoids, Neural Synchrony, and Information Processing

    Conditions:   Cannabis;   Psychotic Disorders
    Interventions:   Drug: THC;   Drug: Placebo
    Sponsors:   Yale University;   Yale University;   National Institute on Drug Abuse (NIDA)
    Recruiting - verified July 2011
  • Cannabis for Spasticity in Multiple Sclerosis

    Condition:   Multiple Sclerosis
    Interventions:   Drug: Smoked Cannabis;   Drug: Smoked Cannabis and oral marinol;   Drug: Placebo
    Sponsors:   University of California, Davis;   University of California, Davis;   National Multiple Sclerosis Society
    Recruiting - verified March 2012
  • Pharmacogenetics of Cannabinoid Response

    Condition:   COMT Gene Polymorphism
    Intervention:   Drug: delta 9 tetrahydrocannabinol
    Sponsors:   Yale University;   Yale University;   National Institute on Drug Abuse (NIDA)
    Recruiting - verified July 2011
  • Cannabinoid Receptor Function & Alcoholism

    Condition:   Alcoholism
    Interventions:   Drug: THC;   Drug: Placebo
    Sponsors:   Yale University;   Yale University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified April 2012
  • Psychopharmacology of Psilocybin in Cancer Patients

    Conditions:   Depressive Symptoms;   Anxiety;   Cancer
    Intervention:   Drug: psilocybin
    Sponsors:   Sidney Kimmel Comprehensive Cancer Center;   Sidney Kimmel Comprehensive Cancer Center;   Heffter Research Institute
    Recruiting - verified October 2011

Main Menu
Clinical Trial Categories
Clinical Trial Locations